SMTL ID : 6e0i.1

Crystal structure of Glucokinase in complex with compound 72

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x GLC: alpha-D-glucopyranose(Non-covalent)

GLC.1: 15 residues within 4Å: Chain A: S.151, F.152, P.153, T.168, K.169, N.204, D.205, T.206, I.225, G.229, C.230, N.231, E.256, Q.287, E.290 13 PLIP interactions: 13 interactions with chain A Hydrogen bonds: A:T.168, A:K.169, A:N.204, A:N.204, A:C.230, A:N.231, A:E.256, A:Q.287 Water bridges: A:G.229, A:G.229, A:C.230, A:E.256 Salt bridges: A:K.169

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 7 residues within 4Å: Chain A: G.81, T.82, I.225, G.227, T.228, G.410, S.411 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.228

1 x HKG: 1-{4-[5-({3-[(2-methylpyridin-3-yl)oxy]-5-[(pyridin-2-yl)sulfanyl]pyridin-2-yl}amino)-1,2,4-thiadiazol-3-yl]piperidin-1 -yl}ethan-1-one(Non-covalent)

HKG.3: 14 residues within 4Å: Chain A: Y.61, V.62, R.63, S.64, P.66, I.159, I.211, Y.214, Y.215, H.218, M.235, L.451, V.452, V.455 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.159, A:I.211, A:Y.214, A:Y.215 Hydrogen bonds: A:R.63, A:R.63 pi-Stacking: A:Y.214

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hinklin, R.J. et al., Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator. Bioorg.Med.Chem. (2020)

Release Date

2019-07-10

Peptides

Glucokinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Glucokinase